Levisetti Matteo 4
4 · Cue Biopharma, Inc. · Filed Jul 25, 2023
Insider Transaction Report
Form 4
Levisetti Matteo
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-07-21+82,500→ 82,500 totalExercise: $4.20Exp: 2033-07-20→ Common Stock (82,500 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in twenty four equal monthly installments beginning on August 21, 2023.